Health Condition 1: M109- Gout, unspecified
Conditions
Interventions
Intervention1: Leech: Leech therapy will be done for 10 days. 4-5 sittings will be done
Control Intervention1: Nil: Nil
Sponsors
National Institute of Siddha
Eligibility
Inclusion criteria
Inclusion criteria: Age 30-65 years All genders. Having classical symptoms of gout- development of maximal inflammation within one day, joint redness, pain, hyperuricemia, suspected tophus, attack of monoarticular arthritis, unilateral attack involving tarsal joint or first metatarsophalangeal joint, more than one attack of acute arthritis and subcortical cyst without erosions (presence of 6 or more findings will be included in the study)
Exclusion criteria
Exclusion criteria: Participants with h/o uncontrolled Diabetes and Hypertension Participants with any bleeding abnormality while taking BT, CT. Immunocompromised patients such as AIDS, Cancer, SLE. Pregnancy and lactation Psychiatric illness Septic arthritis, cellulitis, pseudo gout, and trauma. Participants with anemia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The outcome of the study may reveal the therapeutic effect of Attaividal (Leech therapy) in the management of Narithalai vatham (Gouty arthritis) assessing with the Visual Analogue Scale.A)Range of the score: 0 No pain 1-3 occasionally pain 4-6 Moderate pain 7-10 Severe pain OUTCOME OF THE SCORE: 0 Good improvement 1-3 Moderate improvement 4-6 Mild improvement 7-10 No improvement I.VISUAL ANALOG SCALE: Timepoint: Baseline, each week until 8 week | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in quality of life Timepoint: Baseline, each week until 8 weeks | — |
Countries
India
Contacts
Public ContactDr PERIYASAMI D
National Institute of Siddha
Outcome results
None listed